Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2013

01.07.2013 | Original Article

Prediabetes Is Associated with a High-Risk Colorectal Adenoma

verfasst von: Jae Myung Cha, Joung Il Lee, Kwang Ro Joo, Hyun Phil Shin, Jung Won Jeun, Jun Uk Lim

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Type 2 diabetes mellitus is associated with an increased risk of colorectal neoplasia. However, association between prediabetes and colorectal adenoma has not been reported.

Aims

The aim of this study was to evaluate the relationship between prediabetes and the presence of colorectal adenomas.

Methods

Consecutive prediabetic subjects who underwent screening colonoscopy were enrolled at Kyung Hee University Hospital in Gangdong, Seoul, Korea, between June 2006 and May 2012. Non-prediabetic subjects were separately pooled from the database of the Center for Health Promotion between January 2012 and May 2012. Prediabetes was defined according to the recommendations of the American Diabetes Association. The prevalence of colorectal adenomas and their characteristics were compared between prediabetic and non-prediabetic groups.

Results

The prevalence of colorectal adenoma was higher in prediabetic subjects than in non-prediabetic subjects (39.6 vs. 30.6 %, respectively, p = 0.019). Prediabetic subjects had more multiple and high-risk adenomas than the control group in non-matched analysis (p = 0.000, respectively). In age-matched analysis, the prevalence of multiple and high-risk adenomas were significantly higher in a prediabetic group than those in a control group (44.4 vs. 28.4 %, p = 0.034; 51.9 vs. 34.6 %, p = 0.026, respectively). Furthermore, prediabetes (odds ratio = 2.198; 95 % confidence interval = 1.042–4.637; p = 0.039) was found to be an independent risk factor for a high-risk adenoma by multivariate analysis.

Conclusions

The prevalence of multiple and high-risk colorectal adenomas is significantly higher in the prediabetic subjects than those in the control group. Furthermore, prediabetes was found to be an independent risk factor for a high-risk colorectal adenoma.
Literatur
1.
Zurück zum Zitat Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006–2007. J Korean Med Sci. 2010;25:1113–1121.PubMedCrossRef Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006–2007. J Korean Med Sci. 2010;25:1113–1121.PubMedCrossRef
2.
Zurück zum Zitat Sung JJ, Lau JY, Goh KL, Leung WK. Asia Pacific working group on colorectal cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871–876.PubMedCrossRef Sung JJ, Lau JY, Goh KL, Leung WK. Asia Pacific working group on colorectal cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871–876.PubMedCrossRef
3.
Zurück zum Zitat Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.PubMedCrossRef Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.PubMedCrossRef
4.
Zurück zum Zitat Winaver SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1981.CrossRef Winaver SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1981.CrossRef
5.
Zurück zum Zitat Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol. 1998;147:816–825.PubMedCrossRef Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol. 1998;147:816–825.PubMedCrossRef
6.
Zurück zum Zitat Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91:542–547.PubMedCrossRef Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91:542–547.PubMedCrossRef
7.
Zurück zum Zitat Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol. 2005;3:587–594.PubMedCrossRef Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol. 2005;3:587–594.PubMedCrossRef
8.
Zurück zum Zitat Elwing JE, Gao F, Davidson NO, Early DS. Type 2 diabetes mellitus: the impact on colorectal adenoma in women. Am J Gastroenterol. 2006;101:1866–1871.PubMedCrossRef Elwing JE, Gao F, Davidson NO, Early DS. Type 2 diabetes mellitus: the impact on colorectal adenoma in women. Am J Gastroenterol. 2006;101:1866–1871.PubMedCrossRef
9.
Zurück zum Zitat Chung YW, Han DS, Park KH, Eun CS, Yoo KS, Park CK. Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rectum. 2008;51:593–597.PubMedCrossRef Chung YW, Han DS, Park KH, Eun CS, Yoo KS, Park CK. Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rectum. 2008;51:593–597.PubMedCrossRef
10.
Zurück zum Zitat McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglyceride and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3:687–695.PubMed McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglyceride and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3:687–695.PubMed
11.
Zurück zum Zitat Kang HW, Kim D, Kim HJ, et al. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional case-control study. Am J Gastroenterol. 2010;105:178–187.PubMedCrossRef Kang HW, Kim D, Kim HJ, et al. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional case-control study. Am J Gastroenterol. 2010;105:178–187.PubMedCrossRef
12.
Zurück zum Zitat Rhee SY, Woo JT. The prediabetic period: review of clinical aspects. Diabetes Metab J. 2011;35:107–116.PubMedCrossRef Rhee SY, Woo JT. The prediabetic period: review of clinical aspects. Diabetes Metab J. 2011;35:107–116.PubMedCrossRef
13.
Zurück zum Zitat American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–S69.CrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–S69.CrossRef
14.
Zurück zum Zitat Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastroenterology. 2012;143:844–857.PubMedCrossRef Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastroenterology. 2012;143:844–857.PubMedCrossRef
15.
Zurück zum Zitat DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 1992;15:318–368.PubMedCrossRef DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 1992;15:318–368.PubMedCrossRef
16.
Zurück zum Zitat Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553.PubMedCrossRef Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553.PubMedCrossRef
17.
Zurück zum Zitat Watkins LF, Lewis LR, Levine AE. Characterization of the synergistic effect of insulin and transferring and the regulation of their receptor on a human colon carcinoma cell line. Int J Cancer. 1990;45:372–375.PubMedCrossRef Watkins LF, Lewis LR, Levine AE. Characterization of the synergistic effect of insulin and transferring and the regulation of their receptor on a human colon carcinoma cell line. Int J Cancer. 1990;45:372–375.PubMedCrossRef
18.
Zurück zum Zitat Björk J, Nilsson J, Hultcrantz R, Johansson C. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scan J Gastroenterol. 1993;28:879–884.CrossRef Björk J, Nilsson J, Hultcrantz R, Johansson C. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scan J Gastroenterol. 1993;28:879–884.CrossRef
19.
Zurück zum Zitat Marugame T, Lee K, Eguchi H, et al. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan. Cancer Causes Control. 2002;13:917–921.PubMedCrossRef Marugame T, Lee K, Eguchi H, et al. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan. Cancer Causes Control. 2002;13:917–921.PubMedCrossRef
20.
Zurück zum Zitat Kono S, Honjo S, Todoroki I, et al. Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control. 1998;9:441–446.PubMedCrossRef Kono S, Honjo S, Todoroki I, et al. Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control. 1998;9:441–446.PubMedCrossRef
21.
Zurück zum Zitat Nishii T, Kono S, Abe H, et al. Glucose intolerance, plasma insulin levels, and colon adenomas in Japanese men. Jpn J Cancer Res. 2001;92:836–840.PubMedCrossRef Nishii T, Kono S, Abe H, et al. Glucose intolerance, plasma insulin levels, and colon adenomas in Japanese men. Jpn J Cancer Res. 2001;92:836–840.PubMedCrossRef
22.
Zurück zum Zitat Rhee SY, Woo JT, Chon S, et al. Characteristics of insulin resistance and insulin secretory capacity in Korean subjects with IFG and IGT. Diabetes Res Clin Pract. 2010;89:250–255.PubMedCrossRef Rhee SY, Woo JT, Chon S, et al. Characteristics of insulin resistance and insulin secretory capacity in Korean subjects with IFG and IGT. Diabetes Res Clin Pract. 2010;89:250–255.PubMedCrossRef
23.
Zurück zum Zitat Faerch K, Vaag A, Holst JJ, Glumer C, Pedersen O, Borch-Johnsen K. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia. 2008;51:853–861.PubMedCrossRef Faerch K, Vaag A, Holst JJ, Glumer C, Pedersen O, Borch-Johnsen K. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia. 2008;51:853–861.PubMedCrossRef
24.
Zurück zum Zitat Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care. 2006;29:1909–1914.PubMedCrossRef Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care. 2006;29:1909–1914.PubMedCrossRef
25.
Zurück zum Zitat Kim BJ, Kim YH, Sinn DH, et al. Clinical usefulness of glycosylated hemoglobin as a predictors of adenomatous polyps in the colorectum of middle-aged males. Cancer Causes Control. 2010;21:939–944.PubMedCrossRef Kim BJ, Kim YH, Sinn DH, et al. Clinical usefulness of glycosylated hemoglobin as a predictors of adenomatous polyps in the colorectum of middle-aged males. Cancer Causes Control. 2010;21:939–944.PubMedCrossRef
26.
Zurück zum Zitat Rex DK, Petrini JL, Baron TH, et al. ASGE/ACG taskforce on quality in endoscopy. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101:873–885.PubMed Rex DK, Petrini JL, Baron TH, et al. ASGE/ACG taskforce on quality in endoscopy. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101:873–885.PubMed
Metadaten
Titel
Prediabetes Is Associated with a High-Risk Colorectal Adenoma
verfasst von
Jae Myung Cha
Joung Il Lee
Kwang Ro Joo
Hyun Phil Shin
Jung Won Jeun
Jun Uk Lim
Publikationsdatum
01.07.2013
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2013
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2591-3

Weitere Artikel der Ausgabe 7/2013

Digestive Diseases and Sciences 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.